# CutisPharma, Inc.: Form D filing

CutisPharma, Inc., a pharmaceuticals company in Wilmington, MA, filed a Form D with the SEC in 2014. The latest, on December 30, 2014, reports $20 million sold of a $20 million offering to 2 investors.

Find out what CutisPharma, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20CutisPharma%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=CutisPharma%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fcutispharma-inc-1628863)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20CutisPharma%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=CutisPharma%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fcutispharma-inc-1628863)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Massachusetts](https://specstream.ai/data/form-d/state/massachusetts): 1,533 rows, by operating companies, filed since November 1, 2024, $76.65, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/massachusetts
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 841 WOBURN STREET, Wilmington, MA, 01887
- Phone: (781) 935-8141
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1628863

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Dec 30, 2014 | New notice | $20,000,000 | $20,000,000 | $0 | 2 | Dec 16, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1628863/000162886314000001/0001628863-14-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Neal Muni | Executive Officer, Director |  |
| Indu Muni | Executive Officer, Director |  |
| David J. Parker | Director |  |
| Peter Mione | Executive Officer, Director |  |
| Eric B Lev | Director |  |

## Other pharmaceuticals companies in Massachusetts that filed recently

- [BridgeHealth Pharmaceuticals, Inc.](https://specstream.ai/data/form-d/company/bridgehealth-pharmaceuticals-inc-2162724) $3.5 million · Nov 5, 2026
- [Land Therapeutics Inc.](https://specstream.ai/data/form-d/company/land-therapeutics-inc-2051104) $17.5 million · Oct 21, 2026
- [Crosslink Therapeutics Inc.](https://specstream.ai/data/form-d/company/crosslink-therapeutics-inc-2067583) $5.5 million · Oct 20, 2026
- [Sentonix, Inc.](https://specstream.ai/data/form-d/company/sentonix-inc-2039609) $12.7 million · Aug 20, 2026

[Every Form D from the week of Dec 29, 2014](https://specstream.ai/data/form-d/week/2014-12-29) · [All recent filings in Massachusetts](https://specstream.ai/data/form-d/state/massachusetts) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what CutisPharma, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).